Physician

Rajiv Shamsher Bahadur Vij, M.D.

According to 2025 Medicare claims, Rajiv Vij, M.D. (NPI: 1386814226) practices nephrology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is RAJIV VIJ MD PA (NPI: 1306681077; TIN: 993690074) and primary practice location at 75605-4603.

Vij's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 454 traditional Medicare patients, billed 1,989 HCPCS/CPT codes, and received $146,526 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,980 prescription claims across 338 beneficiaries totaling $291,232 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2020 DME data shows 12 claims. Open Payments data shows 7 records totaling $115. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,699,757 to $291,232. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	821	3,513	$332,933
2016	627	2,663	$220,303
2017	667	2,715	$241,061
2018	642	3,007	$277,519
2019	802	2,925	$316,588
2020	899	3,291	$351,797
2021	754	2,590	$311,225
2022	687	2,238	$249,037
2023	556	2,989	$207,321
2024	454	1,989	$146,526

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	391	3,215	$1,699,757
2016	425	3,772	$1,061,203
2017	396	3,735	$800,238
2018	404	3,490	$385,728
2019	430	3,633	$374,750
2020	422	3,290	$368,112
2021	387	3,249	$272,670
2022	393	3,194	$319,817
2023	370	2,453	$285,919
2024	338	1,980	$291,232

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	30	$225
2017	N/R	45	$506
2018	N/R	11	$864
2019	N/R	40	$6,665
2020	N/R	12	$3,053
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	88	143	$240
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	144	245	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	133	495	$58
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	90	223	$31
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	106	152	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	28	805	$115,770
Farxiga	Dapagliflozin Propanediol	121	5,260	$99,669
Jardiance	Empagliflozin	23	750	$14,486
Kerendia	Finerenone	19	570	$12,316
Sevelamer Carbonate	Sevelamer Carbonate	18	699	$5,697

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$115	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajiv Shamsher Bahadur Vij, M.D.?

Tedicare shows public-source Medicare data for Rajiv Shamsher Bahadur Vij, M.D. (NPI 1386814226), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajiv Shamsher Bahadur Vij, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rajiv Shamsher Bahadur Vij, M.D.?

Rajiv Shamsher Bahadur Vij, M.D. is linked to RAJIV VIJ MD PA (billing NPI 1306681077) in the available physician profile data.

Does Rajiv Shamsher Bahadur Vij, M.D. have Open Payments data?

Rajiv Shamsher Bahadur Vij, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.